Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human ALDH1A3 ELISA Kit (AC3437)
Cat.#: ASET-2026
Specifications
Description Human ALDH1A3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human ALDH1A3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.31 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1376 Human TPP1 ELISA Kit (AC2787) Quantitative inquiry ASET-2209 Mouse TMPRSS2 ELISA Kit (AC3620) Quantitative inquiry ASET-2461 Human GRIP1 ELISA Kit (AC3872) Quantitative inquiry ASET-1959 Sheep TSH ELISA Kit (AC3370) Quantitative inquiry ASET-1862 Mouse CPE ELISA Kit (AC3273) Quantitative inquiry ASET-2230 Rat CD97 ELISA Kit (AC3641) Quantitative inquiry ASET-1606 Rat FGF19 ELISA Kit (AC3017) Quantitative inquiry ASET-2340 Mouse alpha MSH ELISA Kit (AC3751) Quantitative inquiry ASET-2140 Rat Laminin ELISA Kit (AC3551) Quantitative inquiry ASET-1964 Human Prol1 ELISA Kit (AC3375) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket